Prokaryotic Protein Expression


Prokaryotic Protein Expression


engenes_Logo_final1

Products & Services | enGenes Biotech GmbH

Overview

enGenes Biotech has developed the prokaryotic protein expression system enGenes-X-press™ as a leading edge microbial protein production system for optimized protein expression.

Growth decoupled expression of proteins in prokaryotes such as Escherichia coli (E. coli) allows enGenes to develop economic, scalable and efficient production processes within short time frames to make unique biotech products commercially viable.

Advantages of enGenes X-Press prokaryotic protein expression

enGenes X-Press offers a modular platform for gene expression and protein production in E. coli and will be expanded to other prokaryotes, notably Bacillus subtilis, in the near future. This forms the basis for a similarly modular suite of enGenes services focused on the expression of difficult-to-express proteins.

The service menu is divided into a series of steps which can be performed either individually or in combination – with customers able to select which steps they actually need. The modular approach allows more scalable and cost-effective manufacturing processes for recombinant proteins.

Thus the enGenes-X-press technology for growth-decoupled protein production forms a next-generation E. coli expression platform that allows for scalable production of difficult-to-express or even “toxic” recombinant proteins at a fraction of their current cost.

enGenes prokaryotic protein expression services

Based on enGenes X-Press technology and method portfolio, enGenes can deliver improved host cell lines, plasmid expression vectors and optimized production processes to maximize bioprocess efficacy.

Customized project plans also responds to individual documentation requirements to support easy technology transfer to clients’ own facilities and quality management systems.

enGenes X-press forms the key building block in a modular system of customer services for gene expression and optimized protein production in E. coli, Bacillus subtilis and other prokaryotes.

These prokaryotic protein expression services, focused on difficult-to-express proteins, are offered as a series of options or ‘steps’ covering all specific demands along the line from gene to protein.

These steps, which can be performed individually or in combination, comprise:

  • Cloning / Vector optimization
  • Generation of expression strain and host cell engineering
  • Feasibility studies for enGenes-X-press technology
  • Upstream- and Downstream process development
  • Production of non-GMP material for research in mg- to g-scale

Along with the regular project updates, clients also receive step-by-step progress reports with detailed documentation to comply with their internal quality systems.

Resources

Click on enGenes prokaryotic protein expression for more information.
Click on enGenes Biotech GmbH to contact the company directly.


Supplier Information
Supplier: enGenes Biotech GmbH
Address: Mooslackengasse 17, 1190 Vienna, Austria
Tel: +43 1 93 46 707-0
Website: http://www.engenes.cc


Comments are closed.